Sinopharm Group (H) Dividend yield




   HKD/share 
 Price  20.30
 Dividend  0.83
 Earnings  2.94
 Cash-flow  2.71
 Book value  22.56
 Equity  20.14

Sinopharm Group (H) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Sinopharm Group (H) is a company from China, and his stocks are publicly traded.

Sinopharm Group (H) paid a total dividend of 2,590 million HKD last year, for a market value of 63,356 millions (Market Cap 25,422 millions). Dividend per share of Sinopharm Group (H) is 0.83 HKD, and his stock market price 20.30 HKD.

According to the chart below, where dividend yield is displayed, Sinopharm Group (H) has a dividend yield of 4.09%, which is higher than the amount offered by both the market average and companies from China. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Sinopharm Group (H) dividend yield with other Pharmaceuticals and Biotechnology companies or firms from China.

Dividend yield of Sinopharm Group (H)

Sinopharm Group (H) Dividend Payout

About the ability of Sinopharm Group (H) to maintain his current dividend of HKD 0.83 per share, an amount that accounts for 4.09%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Sinopharm Group (H) payout on ernings is currently 28.23%, which is lower than the market average and companies of Health Care industry, which are 39.27% and 31.41% respectively. Both figures lead us to believe that there is confidence that Sinopharm Group (H)can maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Sinopharm Group (H) is HKD 2.71 per share, which is higher than the dividend per share paid by the company of HKD 0.83, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Sinopharm Group (H), compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Sinopharm Group (H) payout

Sinopharm Group (H) Dividend History

Year Yield  HKD  Paypout  Shares* 
Present4.09%0.8328.23%3,121
20203.77%0.7127.84%3,121
20192.32%0.6628.82%2,972
20182.09%0.6930.40%2,767
20171.78%0.6028.04%2,767
20161.33%0.4829.63%2,767
20151.15%0.3727.21%2,767

*In millions

Sinopharm Group (H) Stock performance

Finally, last moth Sinopharm Group (H) showed a return of 1.60% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a 24.80% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.

Sinopharm Group (H) stock and market return